Linezolid versus Vancomycin Antibiotic Lock Solution for the Prevention of Nontunneled Catheter-related Blood Stream Infections in Hemodialysis Patients: A Prospective Randomized Study

Seminars in Dialysis

Volumn 25, Issue 3, 2012, Pages 344-350

  Sofroniadou, Sofia ^a,c   Revela, Ioanna ^a   Smirloglou, Despina ^a   Makriniotou, Ioanna ^a   Zerbala, Sinodi ^a   Kouloubinis, Alexandros ^b   Samonis, George ^c   Iatrou, Christos ^a  

^a GENERAL HOSPITAL OF NIKEA   (Greece)

^b ONASSIS CARDIAC SURGERY CENTER   (Greece)

^c UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAMIDE DERIVATIVE; ANTIINFECTIVE AGENT; LINEZOLID; OXAZOLIDINONE DERIVATIVE; RNA 23S; VANCOMYCIN;

AGED; ARTICLE; BACTEREMIA; CATHETER INFECTION; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HUMAN; INDWELLING CATHETER; INSTRUMENTATION; MALE; MICROBIOLOGY; MIDDLE AGED; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY; TREATMENT OUTCOME;

ACETAMIDES; AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; BACTEREMIA; CATHETER-RELATED INFECTIONS; CATHETERS, INDWELLING; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; OXAZOLIDINONES; PROSPECTIVE STUDIES; RENAL DIALYSIS; RNA, RIBOSOMAL, 23S; TREATMENT OUTCOME; VANCOMYCIN;

EID: 84861233853     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2011.00965.x     Document Type: Article

References (46)

1. Vanholder R, Canaud B, Fluck R, Jadoul M, Labriola L, Marti-Monros A, Tordoir J, Van Biesen W: Catheter-related blood stream infections (CRBSI): a European view. Nephrol Dial Transplant 25:1753-1756, 2010
2. Vascular Access 2006 Work Group: KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for 2006 Updates: HD adequacy, peritoneal dialysis adequacy and vascular access. Am J Kidney Dis 48(Suppl 1):S1-S322, 2006
3. Pisoni RL, Young EW, Dykstra DM, Greenwood RN, Hecking E, Gillespie B, Wolfe RA, Goodkin DA, Held PJ: Vascular access use in Europe and the United States: results from the DOPPS. Kidney Int 61:305-316, 2002
4. Lee T, Barker J, Allon M: Tunneled catheters in HD patients: reasons and subsequent outcomes. Am J Kidney Dis 46:501-508, 2005
5. Powe NR, Jaar B, Furth SL, Hermann J, Briggs W: Septicemia in dialysis patients: incidence, risk factors, and prognosis. Kidney Int 55:1081-1090, 1999
6. Ishani A, Collins AJ, Herzog CA, Foley RN: Septicemia, access and cardiovascular disease in dialysis patients: the USRDS Wave 2 study. Kidney Int 68:311-318, 2005
7. Raad I: Intravascular-catheter-related infections. Lancet 351:893-898, 1998
8. Schwab SJ, Beathard GA: The HD catheter conundrum: Hate living with them, but can't live without them. Kidney Int 56:1-17, 1999
9. Marr KA, Sexton DJ, Conlon PJ, Corey GR, Schwab SJ, Kirkland KB: Catheter-related bacteremia and outcome of attempted catheter salvage in patients undergoing HD. Ann Intern Med 127:275-280, 1997
10. Tanriover B, Carlton D, Saddekni S, Hamrick K, Oser R, Westfall AO, Allon M: Bacteremia associated with tunnelled dialysis catheters: comparison of two treatment strategies. Kidney Int 57:2151-2155, 2000
11. Lok CE, Stanley KE, Hux JE, Richardson R, Tobe SW, Conly J: HD infection prevention with polysporin ointment. J Am Soc Nephrol 13:169-179, 2003
12. Saad TF: Bacteremia associated with tunnelled, cuffed HD catheters. Am J Kidney Dis 34:1114-1124, 1999
13. Kairaitis LK, Gottlieb T: Outcome and complications of temporary haemodialysis catheters. Nephrol Dial Transplant 14:1710-1714, 1999
14. Oliver MJ, Callery SM, Thorpe KE, Schwab SJ, Churchill DN: Risk of bacteremia from temporary HD catheters by site of insertion and duration of use: a prospective study. Kidney Int 58:2543-2545, 2000
15. Beathard GA: Catheter management protocol for catheter-related becteremia prophylaxis. Semin Dial 16:403-405, 2003
16. Johnson DW, MacGinley R, Kay TD, Hawley CM, Campbell SB, Isbel NM, Hollett P: A randomized controlled trial of topical exit site mupirocin application in patients with tunnelled, cuffed haemodialysis catheters. Nephrol Dial Transplant 17:1802-1807, 2002
17. Kamal GD, Pfaller MA, Rempe LE, Jebson PJ: Reduced intravascular catheter infection by antibiotic bonding. A prospective, randomized, controlled trial. JAMA 265:2364-2368, 1991
18. Dahlberg PJ, Agger WA, Singer JR, Yutuc WR, Newcomer KL, Schaper A, Rooney BL: Subclavian HD catheter infections: a prospective, randomized trial of an attachable silver-impregnated cuff for prevention of catheter-related infections. Infect Control Hosp Epidemiol 16:506-511, 1995
19. Dittmer ID, Sharp D, McNulty CAM, Williams AJ, Banks BA: A prospective study of central venous HD catheter colonisation and peripheral bacteremia. Clin Nephrol 51:34-39, 1999
20. Costerton JW, Stewart PS, Greenberg EP: Bacterial biofilms: a common cause of persistent infections. Science 284:1318-1322, 1999
21. Curtin J, Cormican M, Fleming G, Keelehan J, Colleran E: Linezolid compared with eperezolid, vancomycin, and gentamicin in an in vitro model of antimicrobial lock therapy for Staphylococcus epidermidis central venous catheter-related biofilm infections. Antimicrob Agents Chemother 47:3145-3148, 2003
22. Pearson ML: Guideline for prevention of intravascular devicerelated infections. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 17:438-473, 1996
23. Mermel LA, Farr BM, Sherertz RJ, Raad II, O'Grady N, Harris JS, Craven DE, Infectious Diseases Society of America, American College of Critical Care Medicine, Society for Healthcare Epidemiology of America: Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 32:1249-1272, 2001
24. Collignon PJ, Munro R: Laboratory diagnosis of intravascular catheter associated sepsis. Eur J Clin Microbiol Infect Dis 8:807-814, 1989
25. Abb J: In vitro activity of linezolid, quinupristin-dalfopristin, vancomycin, teicoplanin, moxifloxacin and mupirocin against methicillin-resistant Staphylococcus aureus: comparative evaluation by the Etest and a broth microdilution method. Diagn Microbiol Infect Dis 43:319-321, 2002
26. Till M, Wixson RL, Pertel PE: Linezolid treatment for osteomyelitis due to vancomycin-resistant Enterococcus faecium. Clin Infect Dis 34:1412-1414, 2002
27. Yanagihara K, Kaneko Y, Sawai T, Miyazaki Y, Tsukamoto K, Hirakata Y, Tomono K, Kadota J, Tashiro T, Murata I, Kohno S: Efficacy of linezolid against methicillin-resistant or vancomycin insensitive Staphylococcus aureus in a model of hematogenous pulmonary infection. Antimicrob Agents Chemother 46:3288-3291, 2002
28. Champney WS, Miller M: Linezolid is a specific inhibitor of 50S ribosomal subunit formation in Staphylococcus aureus cells. Curr Microbiol 44:350-356, 2002
29. Eliopoulos GM: Quinupristin-dalfopristin and linezolid: evidence and opinion. Clin Infect Dis 36:473-481, 2003
30. Castagnola E, Moroni C, Gandullia P, Oddone M, Peri C, Casciaro R, De Alessandri A: Catheter lock and systemic infusion of linezolid for treatment of persistent Broviac catheter-related staphylococcal bacteremia. Antimicrob Agents Chemother 50:1120-1121, 2006
31. Kim SH, Song KI, Chang JW, Kim SB, Sung SA, Jo SK, Cho WY, Kim HK: Prevention of uncuffed HD catheter-related bacteremia using an antibiotic lock technique: a prospective, randomized clinical trial. Kidney Int 69:161-164, 2006
32. McIntyre CW, Hulme LJ, Taal M, Fluck RJ: Locking of tunneled HD catheters with gentamicin and heparin. Kidney Int 66:801-805, 2004
33. Dogra GK, Herson H, Hutchison B, Irish AB, Heath CH, Golledge C, Luxton G, Moody H: Prevention of tunnelled HD catheter-related infections using catheter-restricted filling with gentamicin and citrate: a randomized controlled study. J Am Soc Nephrol 13:2133-2139, 2002
34. Saxena AK, Panhotra BR, Sundaram DS, Al-Hafiz A, Naguib M, Venkateshappa CK, Abu-Oun BA, Hussain SM, Al-Ghamdi AA: Tunneled catheters' outcome optimization among diabetics on dialysis through antibiotic-lock placement. Kidney Int 70:1629-1635, 2006
35. Saxena AK, Panhotra BR, Sundaram DS, Morsy MN, Al-Ghamdi AM: Enhancing the survival of tunnelled HD catheters using an antibiotic lock in the elderly: a randomized, double-blind clinical trial. Nephrology 11:299-305, 2006
36. Jaffer Y, Selby NM, Taal MW, Fluck RJ, McIntyre CW: A meta-analysis of HD catheter locking solutions in the prevention of catheter-related infection. Am J Kidney Dis 51:233-241, 2008
37. Labriola L, Ralph Crott R, Jadoul M: Preventing haemodialysis catheter-related bacteraemia with an antimicrobial lock solution: a meta-analysis of prospective randomized trials. Nephrol Dial Transplant 23:1666-1672, 2008
38. Moran JE, Ash SR: Locking solutions for hemodialysis catheters; heparin and citrate - a position paper by ASDIN. Semin Dial 21:490-492, 2008
39. Karaaslan H, Peyronnet P, Benevent D, Lagarde C, Rince M, Leroux-Robert C: Risk of heparin lock-related bleeding when using indwelling venous catheter in haemodialysis. Nephrol Dial Transplant 16:2072-2074, 2001
40. Yevzlin AS, Sanchez RJ, Hiatt JG, Washington MH, Wakeen M, Hofmann RM, Becker YT: Concentrated heparin lock is associated with major bleeding complications after tunneled hemodialysis catheter placement. Semin Dial 20:351-354, 2007
41. Tyler LS, Rehder TL, Davis RB: Effect of gentamicin on heparin activity. Am J Hosp Pharm 38:537-540, 1981
42. Droste JC, Jeraj HA, MacDonald A, Farrington K: Stability and in vitro efficacy of antibiotic-heparin lock solutions potentially useful for treatment of central venous catheter-related sepsis. J Antimicrob Chemother 51:849-855, 2003
43. Robinson JL, Tawfik G, Saxinger L, Stang L, Etches W, Lee B: Stability of heparin and physical compatibility of heparin/antibiotic solutions in concentrations appropriate for antibiotic lock therapy. J Antimicrob Chemother 56:951-953, 2005
44. Tokars JI: Vancomycin use and antimicrobial resistance in HD centers. Am J Kidney Dis 32:521-523, 1998
45. Landry DL, Braden GL, Gobeille SL, Haessler SD, Vaidya CK, Sweet SJ: Emergence of gentamicin-resistant bacteremia in hemodialysis patients receiving gentamicin lock catheter prophylaxis. Clin J Am Soc Nephrol 5:1799-1804, 2010
46. Allon M: Prophylaxis against dialysis catheter-related bacteremia: a glimmer of hope. Am J Kidney Dis 51:165-168, 2008